retrospect
studi
editor
liver
injuri
observ
patient
incid
rang
examin
liver
injuri
pattern
implic
nonalcohol
fatti
liver
diseas
nafld
clinic
outcom
chines
patient
januari
februari
consecut
patient
admit
design
hospit
china
confirm
inform
nafld
statu
studi
diagnosi
clinic
manag
patient
conduct
accord
practic
guidelin
issu
chines
nation
health
commiss
confirm
detect
sever
acut
respiratori
syndrom
coronaviru
sequenc
throat
swab
revers
transcript
pcr
liver
injuri
defin
hepatocellular
alanin
aminotransferas
alt
level
iul
male
iul
femal
criteria
discharg
includ
follow
condit
bodi
temperatur
remain
normal
day
signific
improv
respiratori
symptom
resolut
pulmonari
imag
inflamm
repeat
test
least
hour
apart
confirm
clearanc
use
hsi
taken
either
complet
recoveri
discharg
record
patient
within
month
diagnosi
patient
follow
till
discharg
recoveri
diseas
progress
studi
approv
ethic
committe
fysph
fifth
medic
center
plagh
signific
clinic
characterist
admiss
assess
univari
multivari
logist
regress
analysi
investig
independ
risk
factor
diseas
progress
p
valu
consid
signific
two
hundr
two
consecut
patient
confirm
inform
relat
nafld
statu
studi
liver
injuri
observ
patient
admiss
hospit
respect
almost
liver
injuri
mild
hepatocellular
pattern
ductular
mix
pattern
sixtyseven
patient
persist
abnorm
liver
function
admiss
last
followup
thirtynin
progress
stabl
diseas
respect
patient
progress
diseas
older
higher
bmi
higher
percentag
comorbid
nafld
similar
report
studi
show
liver
injuri
patient
frequent
mild
natur
pattern
liver
injuri
mostli
hepatocellular
rather
cholestat
interest
shown
biliari
cell
high
express
angiotensinconvert
enzym
receptor
high
affin
spike
protein
respiratori
viral
infect
hepat
relat
collater
damag
mediat
virusspecif
effector
cell
gener
respons
pulmonari
infect
postmortem
liver
biopsi
one
patient
show
microvesicular
steatosi
accompani
overactiv
cell
suggest
liver
injuri
like
immun
mediat
rather
result
direct
cytopath
damag
describ
viral
respiratori
diseas
major
patient
seri
persist
liver
injuri
nafld
high
bmi
patient
nafld
also
higher
risk
progress
sever
longer
viral
shed
time
increas
global
preval
nafld
may
suggest
larg
proport
popul
could
risk
sever
underli
mechan
unknown
might
relat
impair
innat
immun
viru
particular
abund
receptor
small
intestin
clinic
patient
complain
abdomin
pain
diarrhea
circul
viru
via
hepat
reticular
system
expect
given
rich
suppli
blood
liver
small
bowel
liver
contain
largest
number
macrophag
kupffer
cell
bodi
potent
cytokin
produc
impair
hepat
innat
immun
statu
might
play
critic
role
outcom
postul
patient
nafld
polar
statu
hepat
macrophag
might
skew
inflammationpromot
macrophag
inflammationsuppress
macrophag
lead
progress
howev
better
understand
role
nafld
may
therapeut
implic
work
fund
capit
characterist
clinic
project
beij
municip
scienc
technolog
commiss
acknowledg
healthcar
worker
involv
diagnosi
treatment
patient
hospit
